RANI

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) is a clinical-stage biotherapeutics company founded in 2012 and headquartered in San Jose, California. The company went public in July 2021 and has developed a revolutionary oral drug delivery platform called the RaniPill capsule, which aims to transform how patients receive biologic medications by replacing injections with oral pills. Rani focuses on converting injectable biologics into orally administered treatments across multiple therapeutic areas including immunology, endocrinology, and obesity management.